Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-005034·PLIANT THERAPEUTICS, INC.
Schedule 13G ownership disclosure
PLIANT THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 729139105
Event date: 2025-09-30
- Filing-level shares
- 4,504,817.00
- Percent of class
- 7.3%
- Woodline Partners LP
Shares: 4,504,817.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-005034
- Form type
- SCHEDULE 13G
- Filer
- PLIANT THERAPEUTICS, INC.
- CIK
- CIK 1746473
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership